A vaccine that stops people passing on the malaria parasite to others would benefit communities rather than individuals — since individuals could still become infected with the malaria parasite. This report summarises this and other conclusions of a 1999 meeting between international scientists and representatives of industry, funding agencies and the World Health Organization to discuss the feasibility of developing and using such a vaccine to control and prevent malaria in different types of epidemics.

Go to key document